Health and Healthcare Research

RAND Europe's growing health and healthcare portfolio brings together a multidisciplinary team with backgrounds in public health, health services research, clinical medicine, economics, psychology and systems design.

We work in close partnership with The Health Improvement Studies Institute (THIS) to help generate practical, actionable evidence that can support sustainable improvements in healthcare service provision and long-term patient benefit. The Cambridge Centre for Health Services Research (CCHSR) is also a key collaborator.

Featured Research

Selected Research

  • Pregnant woman visiting doctor for checkup, photo by Halfpoint/Adobe Stock

    Understanding the UK's pregnancy research needs and priorities

    A review of the research needs and expenditure on pregnancy in the UK found that £51 million is invested in pregnancy research each year. By contrast, the NHS spends £5.8 billion on pregnancy-related care each year and in 2018/19 litigation claims totalled £2.5 billion.

  • mosquito sucking blood

    Economic benefits of malaria control

    Investing in malaria vaccination for children in sub-Saharan Africa not only helps in reducing malaria cases and deaths, it could also have long term macroeconomic benefits according to an economic model researchers developed.

  • Healthy vegetable lunch box on working desk

    Supporting the Asia's Healthiest Workplace Competition

    For three years, RAND Europe has supported AIA Vitality's contest. Doing so enables researchers to explore the health trends—employee lifestyle, clinical indicators, mental health and other areas of concern—among participating Asia-Pacific workplaces.

  • Smiling employees having meal in office lunchroom, photo by WavebreakMediaMicro/Adobe Stock

    Britain's Healthiest Workplace survey findings

    Absence and presenteeism accounts for an average of 38 days' lost productivity per employee per year, marking an upward trend in lost productivity since 2014, when the number was only 23 days.

  • Orange ribbon raising awareness of leukemia, kidney cancer, multiple sclerosis, photo by Chinnapong/Adobe Stock

    Understanding the societal burden of disease progression in multiple sclerosis

    MS is associated with high economic costs to society that go beyond the costs to the healthcare system, but researchers found limited evidence on the impact of disease progression on patients, carers, and society as a whole.

  • Medical health care science innovation concept, illustration by Panuwat/Adobe Stock

    How does the pharmaceutical industry reuse health data?

    Several important factors can support or hinder the reuse of pharmaceutical data in the EU, including the availability, interoperability and quality of data; data analytic skills and experience; and the presence of clear and uniform regulations.

  • Investing in ideas concept, photo by freshidea/Adobe Stock

    Supporting FasterCures' project on biomedical innovation metrics

    Researchers are helping FasterCures in their effort to understand the metrics that currently measure innovation in the biomedical ecosystem. They will also establish to what degree these existing approaches are appropriate and relevant to measure and drive innovation for the benefit of patients.

  • Yoga mat, mobile phone, dumbbells, bottle of water and measuring tape

    Evaluating the Wellbeing Premium Programme

    Small and medium enterprises (SMEs) often find it hard to invest in the health and wellbeing of their employees, or do not invest at all. Researchers are evaluating a randomised controlled trial of a financial incentive programme to improve employee health and wellbeing in SMEs in the West Midlands.